In a report released yesterday, Sean Lavin from BTIG maintained a Hold rating on Abbott Labs (NYSE: ABT). The company’s shares closed yesterday at $70.23.
According to TipRanks.com, Lavin is a 5-star analyst with an average return of 12.8% and a 62.6% success rate. Lavin covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings Inc, Helius Medical Technologies, and Tactile Systems Technology.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abbott Labs with a $78.90 average price target, implying a 12.3% upside from current levels. In a report issued on October 9, Citigroup also maintained a Hold rating on the stock with a $72 price target.
.
See today’s analyst top recommended stocks >>
Abbott Labs’ market cap is currently $123.2B and has a P/E ratio of 139.04. The company has a Price to Book ratio of 4.03.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
